Suchergebnisse - "Raimondo, Vincenzo"

PubPharm (7)

1

Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase

enthalten in: Journal of translational autoimmunity | 2023

von Ferri, C. | Raimondo, V. | Giuggioli, D. | +71

2

COVID-19 and Mixed Cryoglobulinemia Syndrome : Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

enthalten in: Journal of clinical immunology | 2023

von Gragnani, L. | Visentini, M. | Lorini, S. | +28

3

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

enthalten in: Journal of clinical immunology | 2023

von Gragnani, L. | Visentini, M. | Lorini, S. | +28

4

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

enthalten in: Journal of clinical immunology | 2023

von Gragnani, L. | Visentini, M. | Lorini, S. | +28

5

COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity

enthalten in: Journal of clinical immunology | 2023

von Gragnani, L. | Visentini, M. | Lorini, S. | +28

6

Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases

enthalten in: Journal of autoimmunity | 2022

von Ferri, C. | Gragnani, L. | Raimondo, V. | +42

7

Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups

enthalten in: Journal of autoimmunity | 2021

von Ferri, C. | Ursini, F. | Gragnani, L. | +45

1
[1]